Express Scripts, the pharmacy benefits management business of the Cigna Group’s Evernorth, will add three additional biosimilars to its National Preferred Formulary that it said will compete with Humira, the world’s top-selling pharmaceutical drug, in terms of competitive net costs. Humira treats inflammatory and pain conditions.
Express Scripts to offer Humira biosimilars
